BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34558189)

  • 21. Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors: a multiinstitutional retrospective analysis of 41 patients.
    Ogawa K; Toita T; Nakamura K; Uno T; Onishi H; Itami J; Shikama N; Saeki N; Yoshii Y; Murayama S
    Cancer; 2003 Jul; 98(2):369-76. PubMed ID: 12872359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases.
    Kalra M; Adra N; Hanna N; Abonour R; Einhorn LH
    Cancer; 2020 Mar; 126(6):1202-1207. PubMed ID: 31743434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
    Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central Nervous System Germ Cell Tumors: A Review of the Literature.
    Kong Z; Wang Y; Dai C; Yao Y; Ma W; Wang Y
    J Child Neurol; 2018 Aug; 33(9):610-620. PubMed ID: 29848146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
    Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
    Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of endocrine function among young children with newly diagnosed malignant central nervous system tumors treated with irradiation-avoiding regimens.
    Cochrane AM; Cheung C; Rangan K; Freyer D; Nahata L; Dhall G; Finlay JL
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28475292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of myeloablative chemotherapy with autologous hematopoietic cell rescue in central nervous system germ cell tumors.
    Bouffet E
    Pediatr Blood Cancer; 2010 Apr; 54(4):644-6. PubMed ID: 20146220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-seminomatous testicular germ cell tumours. Preliminary analysis of ongoing trials in the DATECA Study.
    Rørth M; von der Maase H; Sandberg Nielsen E; Schultz HP; Svennekjaer IL
    Acta Radiol Oncol; 1984; 23(4):295-304. PubMed ID: 6208750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
    Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R
    N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of serum tumor markers in advanced germ cell tumors with responses to chemotherapy and surgery.
    Vugrin D; Friedman A; Whitmore WF
    Cancer; 1984 Mar; 53(6):1440-5. PubMed ID: 6198071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
    Mann JR; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendszus KR
    Cancer; 1989 May; 63(9):1657-67. PubMed ID: 2467734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of marker half-life in relapsed and nonrelapsed nonseminomatous germ cell testicular tumor patients undergoing chemotherapy.
    Keskin S; Ekenel M; Başaran M; Bavbek S
    Am J Clin Oncol; 2012 Aug; 35(4):369-72. PubMed ID: 22814307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors.
    Mokhtech M; Rotondo RL; Bradley JA; Sandler ES; Nanda R; Logie N; Aldana PR; Morris CG; Indelicato DJ
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26997. PubMed ID: 29380526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late relapsing germ cell tumors with elevated tumor markers.
    Che Y; Lusch A; Winter C; Große Siemer R; Buddensieck C; Albers P; Hiester A
    World J Urol; 2022 Feb; 40(2):363-371. PubMed ID: 34518930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bifocal intracranial tumors of nongerminomatous germ cell etiology: diagnostic and therapeutic implications.
    Aizer AA; Sethi RV; Hedley-Whyte ET; Ebb D; Tarbell NJ; Yock TI; Macdonald SM
    Neuro Oncol; 2013 Jul; 15(7):955-60. PubMed ID: 23640532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors.
    Kim JW; Kim WC; Cho JH; Kim DS; Shim KW; Lyu CJ; Won SC; Suh CO
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):625-31. PubMed ID: 22420971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical characteristics and treatment outcome of 57 children and adolescents with primary central nervous system germ cell tumors.
    Sun XF; Zhang F; Zhen ZJ; Yang QY; Xia YF; Wu SX; Zhu J; Lu SY; Wang J; Sun FF; Cai RQ; Chen Y; Li PF
    Chin J Cancer; 2014 Aug; 33(8):395-401. PubMed ID: 25011460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
    Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
    Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pineoblastoma in children less than six years of age: The Head Start I, II, and III experience.
    Abdelbaki MS; Abu-Arja MH; Davidson TB; Fangusaro JR; Stanek JR; Dunkel IJ; Dhall G; Gardner SL; Finlay JL
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28252. PubMed ID: 32187454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-fetoprotein in the management of germ cell tumors of the ovary.
    Bonazzi C; Colombo N; Lissoni A; Pittelli MR; Bini S; Mangioni C
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):53-8. PubMed ID: 2480424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.